HSCS Stock Analysis: Buy, Sell, or Hold?
HSCS - HeartSciences Inc. Common Stock
$3.20
-0.03 (-0.93%)
▼
5d:
-0.93%
30d:
+3.56%
90d:
+8.11%
BUY
MODERATE Confidence
Last Updated: February 2, 2026
Earnings: Mar 12, 2026
Get Alerted When HSCS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called HSCS this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: HSCS shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: HSCS shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: HSCS is currently trading at $3.20, which is considered fair relative to its 30-day fair value range of $3.03 to $3.41.
Technical Outlook: Technically, HSCS is in a downtrend. Immediate support is located at $3.08, while resistance sits at $3.70.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.60 (+231.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, HSCS is in a downtrend. Immediate support is located at $3.08, while resistance sits at $3.70.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.60 (+231.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$3.03 -
$3.41
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 231.2% below Wall St target ($10.60)
Fair Price Analysis
30-Day Fair Range
$3.03 -
$3.41
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$3.08
Resistance Level
$3.70
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-1.00
Wall Street Target
$10.60
(+231.2%)
Revenue Growth (YoY)
653.8%
Last updated: February 02, 2026 9:20 PM ET
Data refreshes hourly during market hours. Next update: 10:20 PM
Data refreshes hourly during market hours. Next update: 10:20 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HSCS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$124 | 59 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 69 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 66 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$370 | 57 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 57 HOLD |
